TAIWAN ADVANCE BIO-PHARM INCTAIWAN ADVANCE BIO-PHARM INCTAIWAN ADVANCE BIO-PHARM INC

TAIWAN ADVANCE BIO-PHARM INC

No trades
See on Supercharts

4186 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Taiwan Advance Bio-Pharmaceutical, Inc. engages in the research, development, production, and sale of drug residue testing reagents. It operates through the following business segments: Inspection business, Food safety, Precision medicine, Research and development unit 2, and New business. The Inspection business segment offers drug abuse certification testing services. The Food safety segment offers drug residue detection reagents. The Precision medicine segment provides cord blood preservation as well as testing and cord blood gene related customer services. The Research and development unit 2 segment includes the development of new drugs and hematopoietic stem cell proliferation technology. The New business segment offers genetic testing and business services. The company was founded on May 25, 2000 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4186 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company